Apollomics, Inc. (APLM:NASDAQ) closed at $17.68 on November 13, 2026, up 2.20% on the day. The stock trades 37.5% below its 52-week high of $28.29 and 40.5% above its 52-week low of $12.58. Over the past year, it lost 17.6%. Apollomics, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, APLM closed higher on 106 days (42%). Its best day was August 14, 2026 (+34.72%) and its worst was July 13, 2026 (-25.01%). The stock moved 10% or more in a single session 29 times. It opened at least 5% above the previous day's high 2 times.
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.
Find more stocks like APLM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.